If you're ready to spend less time on your phone in 2026, try picking up a screen-free hobby. We found beginner-friendly ways ...

Antibody drug conjugates (ADCs) mark a new era in targeted cancer therapy, delivering potent cytotoxic chemotherapy via monoclonal antibodies directly into the tumor cells — an era with potentially ...

Antibody–drug conjugates (ADCs) in oncology have been some of the most sought-after assets in the biopharma dealmaking landscape in the past two years. For example, in 2023, Pfizer purchased Seagen, ...

What if the tools you’ve relied on for years were no longer the best option? For decades, mechanical keyboards have been the gold standard for gamers, programmers, and typists alike, celebrated for ...

While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...

EBC-129 has been granted FDA fast track designation for the treatment of pancreatic ductal adenocarcinoma, paving the way for development of this antibody-drug conjugate. EBC-129, a novel ADC for the ...

In this tutorial, we will be learning to use an analog to digital converter, or ADC, which communicates to our ESP32 using the SPI serial interface. This file contains hidden or bidirectional Unicode ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed antibody-drug conjugate (ADC) after failing to show a favorable benefit-risk profile ...

Abstract: MAGICAL is an open-source system for analog and mixed-signal (AMS) circuit layout synthesis. Using custom place-and-route and constraint extraction algorithms, MAGICAL provides a ...